Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
Journal of Drugs in Dermatology : JDD
|
September 17, 2014
The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis
Mirna E Toledo-Bahena, Alicia Bucko, Jorge Ocampo-Candiani, et al.
Biological Trace Element Research
|
December 20, 2024
Effects of Supranutritional Selenium Supplementation During Different Trimesters of Pregnancy on Humoral Immunity in Beef Cattle at Parturition
Jean A Hall, Gerd Bobe, William R Vorachek, et al.
American Journal of Veterinary Research
|
July 2, 2009
Serum elimination profiles of methyllycaconitine and deltaline in cattle following oral administration of larkspur (Delphinium barbeyi)
Benedict T Green, Kevin D Welch, Dale R Gardner, et al.
Journal of the American Academy of Dermatology
|
August 22, 2017
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis
Lawrence F Eichenfield, Robert S Call, Douglass W Forsha, et al.
Journal of Agricultural and Food Chemistry
|
August 5, 2010
Tremetone and structurally related compounds in white snakeroot ( Ageratina altissima ): a plant associated with trembles and milk sickness
Stephen T Lee, T Zane Davis, Dale R Gardner, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 27, 2025
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
Lise I Loberg, William R Proctor, Andrew D Burdick, et al.
Journal of Animal Science
|
February 18, 2019
Sex-dependent differences for larkspur (Delphinium barbeyi) toxicosis in yearling Angus cattle1
Benedict T Green, John W Keele, Dale R Gardner, et al.
Journal of the American Academy of Dermatology
|
July 16, 2016
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
Amy S Paller, Wynnis L Tom, Mark G Lebwohl, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
Journal of Drugs in Dermatology : JDD
|
September 17, 2014
The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis
Mirna E Toledo-Bahena, Alicia Bucko, Jorge Ocampo-Candiani, et al.
Biological Trace Element Research
|
December 20, 2024
Effects of Supranutritional Selenium Supplementation During Different Trimesters of Pregnancy on Humoral Immunity in Beef Cattle at Parturition
Jean A Hall, Gerd Bobe, William R Vorachek, et al.
American Journal of Veterinary Research
|
July 2, 2009
Serum elimination profiles of methyllycaconitine and deltaline in cattle following oral administration of larkspur (Delphinium barbeyi)
Benedict T Green, Kevin D Welch, Dale R Gardner, et al.
Journal of the American Academy of Dermatology
|
August 22, 2017
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis
Lawrence F Eichenfield, Robert S Call, Douglass W Forsha, et al.
Journal of Agricultural and Food Chemistry
|
August 5, 2010
Tremetone and structurally related compounds in white snakeroot ( Ageratina altissima ): a plant associated with trembles and milk sickness
Stephen T Lee, T Zane Davis, Dale R Gardner, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 27, 2025
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
Lise I Loberg, William R Proctor, Andrew D Burdick, et al.
Journal of Animal Science
|
February 18, 2019
Sex-dependent differences for larkspur (Delphinium barbeyi) toxicosis in yearling Angus cattle1
Benedict T Green, John W Keele, Dale R Gardner, et al.
Journal of the American Academy of Dermatology
|
July 16, 2016
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
Amy S Paller, Wynnis L Tom, Mark G Lebwohl, et al.
Page
of 9